Abstract
Transcarotid artery revascularization (TCAR) is a novel and attractive alternative to carotid endarterectomy (CEA) or transfemoral carotid artery stenting for interventional treatment of carotid artery stenosis in high-risk patients. In a direct carotid approach, TCAR uses temporary reversal of cerebral arterial blood flow to offer neuroprotection from emboli during stent placement. At present, the optimal surgical management for high-risk patients is unknown. We aimed to evaluate the 1-year safety and efficacy of TCAR in a prospective clinical trial.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
